Pune, Aug. 11, 2020 (GLOBE NEWSWIRE) -- The global continuous renal replacement therapy market size is expected to gain momentum and reach USD 1,811.5 million by 2027 on account of the increasing prevalence of chronic diseases such as diabetes that leads to kidney issues. A published report by Fortune Business Insights titled, “Continuous Renal Replacement Therapy (CRRT) Market Size, Share & COVID-19 Impact Analysis, By Product Type (Systems, and Consumables), By Modality (Slow continuous ultrafiltration {SCUF}, Continuous Venovenous Hemofiltration {CVVH}, Continuous Venovenous Hemodialysis {CVVHD}, and Continuous Venovenous Hemodiafiltration {CVVHDF), and Regional Forecast, 2020-2027,” states that the value of this market was USD 986.4 million in the year 2019 and will exhibit a CAGR of 8.0% between 2020 and 2027.
Gain more insights into the Continuous Renal Replacement Therapy (CRRT) Market: https://www.fortunebusinessinsights.com/continuous-renal-replacement-therapy-crrt-market-102547
Highlights of the Report
The report offers a comprehensive overview of the market focusing on growth drivers, restraints, challenges, and upcoming opportunities. It also discusses the competitive landscape of the market, and lists the current trends and industry developments of the market. The report further highlights the table of segmentation and the names of the leading segments with market figures. To purchase this report, log on to the company website.
Drivers & Restraints-
Increasing Prevalence of Acute Kidney Injury to Propel Growth
Some of the factors promoting the continuous renal replacement therapy market growth include the increasing prevalence of chronic diseases such as diabetes, hypertension, and others that ultimately leads to kidney disorders. In addition to this, the rise in geriatric population and the increasing cases of acute kidney problems are likely to add impetus to the market in the coming years. Moreover, the rise in coronavirus positive cases mostly among the geriatric population and the rising rate of kidney cases among severely ill patients are likely to augment demand for continuous renal replacement therapy in the forthcoming years.
However, the stringent regulations imposed by the Food and Drug Administration on the approval of various products may pose a serious challenge to the market in the coming years. Nevertheless, the advent of medical technologies and rising investments in research and development of novel therapeutics are likely to create lucrative opportunities for the CRRT market in the coming years.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/continuous-renal-replacement-therapy-crrt-market-102547
The current pandemic of Covid-19 has made a catastrophic impact on the world. Most businesses are shut as a result of the increasing COVID-19 cases. The healthcare industry is facing shortage of medical aid as there are not enough beds to suffice the needs of the increasing number of patients. The world economy is fluctuating as most businesses are at a halt and the ones running from the vicinity of their homes are barely able to manage revenue.
Special reports on various markets affected by the coronavirus pandemic are provided by Fortune Business Insights. These reports will help visualize the current situation and what strategies can be adopted to help the market gain momentum in the coming years.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/continuous-renal-replacement-therapy-crrt-market-102547
Segmentation-
Consumables Segment is Overpowering Market with Increasing Application of Hemofilter
In 2019, the consumable products segment earned the highest CRRT market share on account of the increasing application of consumables such as fluids, hemofilter, and charcoal filters among others. However, the increasing prevalence of acute kidney injuries are likely to help the systems segment witness steady growth in the coming years.
Regional Analysis-
North America is Dominating Market Owing to Rising Demand for Radical Innovation in Machines
In 2019, North America held the largest CRRT market share with a revenue of USD 354.3 million. This is attributable to the increasing demand for continuous renal replacement therapy and radical innovation in the machines. This, coupled with the increasing prevalence of kidney diseases especially in the U.S. Furthermore, the Asia Pacific market is expected to register fastest growth in the coming years owing to the rise in expenditure on the infrastructural development of healthcare sector in the developing nations.
Competitive Landscape-
Companies Engaging in Geographical Expansion to Gain Competitive Edge
The nature of the CRRT market is monopolistic on account of the dominance of Baxter International Inc. Some of the companies operating in this market are engaging in improving their portfolio by investing on latest innovations and new devices. The other players are engaging in joint ventures, contracts and agreements, and other collaborative efforts to gain a significant position in the market competition.
Quick Buy - Continuous Renal Replacement Therapy (CRRT) Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102547
Some Industry Developments of the CRRT Market include:
February 2019 – NxStage Medical and Fresenius Medical Care entered into strategic collaboration soon after the approval of antitrust authorities in the U.S. The main objective behind the adoption of this strategy is to strengthen the supply chain of both the companies, along with their production and manufacturing competencies across various products and services.
List of the Leading Companies Profiled in the Continuous Renal Replacement Therapy (CRRT) Market Report are:
- B. Braun Medical Inc. (Pennsylvania, United States)
- Asahi Kasei Corporation (Tokyo, Japan)
- Toray Medical Co., Ltd (Tokyo, Japan)
- Medtronic Plc
- Baxter International Inc. (Illinois, United States)
- Fresenius Medical Care AG & Co. KGaA (Bad Homburg, Germany)
- NIPRO Corporation (Osaka, Japan)
- NxStage Medical, Inc., (Massachusetts, United States)
- Others
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/continuous-renal-replacement-therapy-crrt-market-102547
Detailed Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Others Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Epidemiology of Acute Kidney Failure by Key Countries
- Reimbursement Scenario for Key Countries
- New Product Type Launch
- Key Industry Developments - Mergers, Acquisitions, and Partnerships
- Global Continuous Renal Replacement Therapy (CRRT) Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product Type
- Systems
- Consumables
- Market Analysis, Insights and Forecast – By Modality
- Slow continuous ultra-filtration (SCUF)
- Continuous Venovenous Hemofiltration (CVVH)
- Continuous Venovenous Hemodialysis (CVVHD)
- Continuous Venovenous Hemodiafiltration (CVVHDF)
- Market Analysis, Insights and Forecast – By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/continuous-renal-replacement-therapy-crrt-market-102547
Have a Look at Related Reports:
Dialysis Market Size, Share & Industry Analysis, By Type (Products and Services), By Dialysis Type (Hemodialysis and Peritoneal Dialysis), By End User (Dialysis Centers & Hospitals and Home Care), and Regional Forecast, 2019-2026
Renal Therapeutics Market Size, Share And Global Trend By Application (Chronic kidney disease, Diabetes, Kidney stone disease, Kidney failure, Others), By Drug Class (Angiotensin-II receptor blockers, ACE Inhibitors, Calcium channel blockers, Beta-blockers, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And Geography Forecast Till 2026
Acute Kidney Failure Treatment Market Size, Share & Industry Analysis, By Disease Indication (Pre-renal Kidney Failure, Post-renal Kidney Failure, Intrinsic Kidney Failure), By Treatment Type (Medications/ Drug Therapy, Urinary Implants) and Regional Forecast, 2019-2026
Chronic Kidney Disease Treatment Market Size, Share and Global Trend By Type of Treatment (Drugs, Dialysis, Transplantation of Kidneys, Others), By End User (Hospitals & Clinics, Ambulatory Surgery Centres (ASCs), Dialysis Centers, Others), and Geography Forecast till 2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/continuous-renal-replacement-therapy-crrt-market-9707